PROFIT - Prostate Fractionated Irradiation Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,204

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 15, 2017

Study Completion Date

July 15, 2017

Conditions
Prostate Cancer
Interventions
PROCEDURE

7800 cGy/39 fractions in 8 weeks

see above

PROCEDURE

6000 cGy/20 fractions in 4 weeks

see above

Trial Locations (25)

2065

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards

2145

Westmead Cancer Care Centre, Wentworthville

2170

Liverpool Hospital & Campbelltown Hospital, Liverpool

2310

Calvary Mater Newcastle Hospital, Newcastle

2500

Wollongong Hospital / Illawarra Cancer Care Centre, Wollongong

3350

Ballarat Austin Radiation Oncology Centre (BAROC), Ballarat

4102

Princess Alexandra Hospital, Woolloongabba

4350

Toowoomba Cancer Research Centre, Toowoomba

8006

Peter MacCallum Cancer Centre, Melbourne

44093

Centre René Gauducheau, Nantes

T4N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

R3E 0V9

CancerCare Manitoba, Winnipeg

A1B 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

L8V 5C2

Juravinski Cancer Centre, Hamilton

N6A 4L6

London Regional Cancer Centre, London

L5M 2N1

The Credit Valley Hospital - Carlo Fidani Peel Regional Cancer Centre, Mississauga

L3Y 2P9

Stronach Regional Cancer Centre, Southlake Regional Health Centre, Newmarket

L1G 2B9

R.S. McLaughlin Durham Regional Cancer Centre, Oshawa

M4N 3M5

Odette Sunnybrook Cancer Centre, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

N8W 1L9

Windsor Regional Cancer Centre, Windsor

H2L 4M1

CHUM - Hôpital Notre-Dame, Montreal

H3G 1A4

Montréal General Hospital, Montreal

S4T 7T1

Allan Blair Cancer Centre, Regina

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Trans Tasman Radiation Oncology Group

OTHER

lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT00304759 - PROFIT - Prostate Fractionated Irradiation Trial | Biotech Hunter | Biotech Hunter